Is my loss of protective sensation in the legs due to peripheral neuropathy rather than stroke demyelination, and should I continue using a wheelchair for mobility?

Peripheral Neuropathy vs. Stroke: Diagnosis and Wheelchair Use

Your loss of protective sensation in the legs is almost certainly due to peripheral neuropathy, not stroke demyelination, and you should continue using your wheelchair if you cannot ambulate safely—wheelchairs improve quality of life and participation without causing harm 1.

Why This Is Peripheral Neuropathy, Not Stroke

Stroke does not cause "demyelination" in the typical sense—stroke causes central nervous system damage from ischemia or hemorrhage. While stroke can secondarily affect peripheral nerves in affected limbs (showing fiber atrophy and demyelination on biopsy 2), this is a consequence of disuse, not a primary demyelinating process. The pattern you describe—bilateral loss of protective sensation in the legs—is the classic "stocking" distribution of peripheral neuropathy, not stroke.

Key distinguishing features:

• Peripheral neuropathy: Symmetrical, distal sensory loss starting in feet, progressing proximally, often with pain/burning 3, 4
• Stroke: Asymmetrical deficits affecting one side of the body, with motor weakness more prominent than pure sensory loss 1

If your symptoms are bilateral and symmetrical in both legs, peripheral neuropathy is the diagnosis. Loss of protective sensation specifically indicates advanced neuropathy with large fiber involvement 5.

Wheelchair Use Is Appropriate and Beneficial

You should absolutely continue using your wheelchair if you cannot ambulate safely. The American Heart Association/American Stroke Association guidelines explicitly state that wheelchairs should be used for individuals who cannot ambulate safely or have concerns about safe/functional ambulation 1. This applies equally to peripheral neuropathy patients with loss of protective sensation.

Critical evidence supporting wheelchair use:

• Up to 40% of stroke patients use wheelchairs at discharge, and this is considered appropriate care 1
• Wheelchair use improves quality of life and community participation 1
• Self-propulsion in wheelchairs is not detrimental to muscle tone or functional outcomes 1
• Many patients use wheelchairs for longer distances (shopping, appointments) while maintaining short-distance home ambulation 1

Loss of protective sensation creates high fall risk 1, and peripheral neuropathy significantly impairs mobility—patients with neuropathy have 47% lower odds of achieving basic mobility and 57% lower odds of advanced mobility compared to those without 6. Using a wheelchair prevents falls and injuries that could be catastrophic.

The Mobility Decision Algorithm

Your mobility aid should be determined by:

1. Can you ambulate safely? If no → wheelchair is indicated 1
2. Do you have loss of protective sensation? If yes → high fall risk, wheelchair likely needed
3. Can you do short distances at home but not community distances? → wheelchair for community, possible assistive device (walker/cane) at home 1

If you have any ambulation ability, consider a hierarchical approach:

• Walker/rollator for maximum stability if you can bear weight and have some balance 1
• Quad cane for moderate support if balance is better 1
• Wheelchair for safety when the above are insufficient or for longer distances 1

Common Pitfalls to Avoid

Do not delay wheelchair use thinking it will cause "dependence"—this is a myth. The evidence shows wheelchair use does not harm functional outcomes 1. Delaying appropriate wheelchair use increases fall risk and reduces quality of life.

Do not assume all leg sensory loss is from stroke—peripheral neuropathy is extremely common (1-7% of general population, much higher in those over 50 4) and is the more likely diagnosis for bilateral symmetrical symptoms.

Get proper evaluation: You need monofilament testing (loss of 5.07 monofilament = loss of protective sensation 7) and potentially nerve conduction studies to confirm peripheral neuropathy 3, 4. The Michigan Neuropathy Screening Instrument (MNSI) detects neuropathy earlier than monofilament testing alone 5.

What You Need Next

1. Confirm the diagnosis: Clinical exam with monofilament testing, consider nerve conduction studies if diagnosis unclear 3, 4
2. Identify the cause: Most common are diabetes (even prediabetes), vitamin B12 deficiency, alcohol use—initial labs should include fasting glucose, B12, thyroid function, complete metabolic panel 4
3. Optimize wheelchair prescription: Should be individualized to your needs, environment, and whether you'll self-propel or need caregiver assistance 1
4. Address neuropathic pain if present: Gabapentinoids or antidepressants are first-line 4

The wheelchair is a tool for safety, independence, and quality of life—not a sign of failure. Use it confidently.